Wall Street analysts expect Cencora (COR) to post quarterly earnings of $4.37 per share in its upcoming report, which indicates a year-over-year increase of 9.3%. Revenues are expected to be $84.89 ...

(Reuters) -Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after forecasting adjusted profit for next year above Wall Street ...

Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon ...

The investments include the opening of a second national distribution center. Cencora is expanding its distribution center in Dothan, Ala. — one of three facilities across its network dedicated to ...

Cencora (COR) shifts to specialty pharma infrastructure, boosting margins via acquisitions and raising FY2026 EPS guidance.

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora accounts ...

James Cleary will retire as executive vice president and chief financial officer effective June 30. “I have had the pleasure of working with Jim for twelve years,” said Mark Durcan, chair of Cencora’s ...

May 7 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs. The ...

Drug distributor Cencora has entered into a definitive agreement to acquire Retina Consultants of America, a management services organization (MSO) of retina specialists, from Webster Equity Partners ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...